Anti-Acne Cosmetics Market Revenue Surge to USD 4.56 Billion By 2028

The global anti-acne cosmetics market size is expected to reach USD 4.56 billion by 2028 according to a new study by Polaris Market Research.

The major driving force behind the growth of anti-acne cosmetic products is the increased use of cosmetic products by men, the emergence of organic cosmetics, and increased urbanization in many developing countries across the globe. Few decades only, women were using anti-acne cosmetic products; however, men are increasingly using cosmetics in recent years.

Several well-known skincare brands are launching anti-acne cosmetic products specifically for men. Previously, most products were chemical-based cosmetics, but in recent years, organic cosmetics were introduced in the industry due to fewer side effects associated with them.

Get an exclusive sample PDF report of Anti-Acne Cosmetics Market @ https://www.polarismarketresearch.com/industry-analysis/anti-acne-cosmetics-market/request-for-sample

According to the clinical data published by Dermatology Times, in April 2021, tazarotene 0.045 % lotion was effective for treating facial acne. The trial was conducted on 1,612 patients by ortho dermatologists, and the lotion improves the quality of life in both moderate and severely affected acne patients.

Creams & lotions dominated the market in 2020, as they're the first line of treatment for all forms of acne and offer surface moisturization. Increased demand for these products, as it provides protection from bacteria and skin diseases such as psoriasis, will further help maintain significant market share during the forecast timeframe.

COVID-19 pandemic is expected to play a less significant role in the growth of the global market. Most of the anti-acne products are used in-home care treatment, which requires no medical advice, and hence even during the pandemic, the consumer base for the products is seeing an upward growth.

Some of the major players operating in the market for anti-acne cosmetics include Clinique, Neutrogena, Murad, LaRochPosay, Kose, Mentholatum, Proactiv, L'Oréal, Ancalima Lifesciences Ltd., Galderma SA, Johnson & Johnson, Doctor Li, and Vichy.

For In-depth Information Enquire Before Purchasing This Report @ https://www.polarismarketresearch.com/industry-analysis/anti-acne-cosmetics-market/inquire-before-buying

Many companies are entering into a collaboration to develop new innovative products.

GlaxoSmithKline entered into USD 224 million partnership with Eligo in January 2021 to develop a treatment known as Eligobiotics that will target bacteria that causes acne. Key companies are also expanding their business to maintain a competitive edge.

In August 2020, Cassiopea SpA in Italy had developed an acne treatment Winlevi (clascoterone cream 1 percent) that has been approved by the U.S. Food and Drug Administration (FDA). Winlevi is the first of its kind acne treatment with a novel mode of action to receive FDA approval in the U.S. In April 2021, Teva Pharmaceuticals announced the U.S. launch of Absorica capsules to treat severe recalcitrant nodular acne in patients aged 12 and above.

Browse detailed reports with in-depth TOC @ https://www.polarismarketresearch.com/industry-analysis/anti-acne-cosmetics-market/toc

Polaris Market Research has segmented the anti-acne cosmetics market report on the basis of product, end-use, and region:

Anti-acne Cosmetics, Product Type (Revenue - USD Million, 2016 - 2028)
• Mask
• Creams & Lotions
• Cleaners & Toners
• Others

Anti-acne Cosmetics, End-Use Outlook (Revenue - USD Million, 2016 - 2028)
• Women
• Men

Contact Us:

Polaris Market Research

Email: sales@polarismarketresearch.com
Ph: +1-929 297-9727
Web: https://www.polarismarketresearch.com

About Us:

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.

This release was published on openPR.